IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H)Joanne Jones, Alasdair Coles, Alastair Compston et al.|Journal of Clinical Investigation|2009Cited by 299
A second major histocompatibility complex susceptibility locus for multiple sclerosisTai Wai Yeo, Stephen Sawcer, Philip L. De Jager et al.|Annals of Neurology|2007Cited by 175
Investigation of the Role of Mitochondrial DNA in Multiple Sclerosis SusceptibilityMaria Ban, Stephen Sawcer, Joanna L. Elson et al.|PLoS ONE|2008Cited by 64
CD24 Ala/Val polymorphism and multiple sclerosisAn Goris, Stephen Sawcer, Amie Walton et al.|Journal of Neuroimmunology|2006Cited by 28